In contrast, in cancers with LBH underexpression, i.e., lung (LUAD), skin (SKCM), and cervical (CESC), reduced LBH expression levels correlated with advanced tumor stage (III and IV; p < 0.05; Fig. 3A.vii–ix). This evidence concerns the gene LBH and neoplasm.